---
schema_version: "secwatch.filing_event.v1"
accession: "0001428336-22-000031"
form_type: "8-K"
ticker: "HQY"
cik: "0001428336"
company_name: "HEALTHEQUITY, INC."
filed_at: "2022-12-06T23:59:59+00:00"
generated_at: "2026-06-21T08:47:18.267848+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# HealthEquity Q3 revenue $216.1M (+20% YoY); narrows net loss; guides FY2024 ~$950-970M

## Summary
- Revenue $216.1M (+20% YoY); net loss $1.6M vs $5.0M loss; non-GAAP diluted EPS $0.38 vs $0.35.
- Adjusted EBITDA $73.4M (+20%); margin 34%; HSAs 7.7M (+23%); total accounts 14.5M (+9%).
- FY2023 outlook: revenue $850-860M; Adj EBITDA $261-271M; non-GAAP EPS $1.26-$1.35.
- FY2024 initial guidance: revenue ~$950-970M; Adj EBITDA margin ~33-34%; assumes ~2.25% cash yield.

## SEC filing metadata
- accession: 0001428336-22-000031
- form_type: 8-K
- ticker: HQY
- cik: 0001428336
- company_name: HEALTHEQUITY, INC.
- filed_at: 2022-12-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1428336/000142833622000031/0001428336-22-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1428336/000142833622000031/hqy-20221206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001428336-22-000031
- JSON: https://secwatch.observer/filing/0001428336-22-000031.json
- Plain text: https://secwatch.observer/filing/0001428336-22-000031.txt

## Key facts
- Earnings Releases
  HEALTHEQUITY, INC. reported third quarter ended October 31, 2022 results: revenue $216.1 million, net income Net loss of $1.6 million, EPS Net loss per diluted share of $0.02.
  - Period: third quarter ended October 31, 2022
  - Revenue: $216.1 million
  - Net income: Net loss of $1.6 million
  - EPS: Net loss per diluted share of $0.02
  - Result: reported results
  source text: Revenue of $216.1 million, an increase of 20% compared to $180.0 million in Q3 FY22. • Net loss of $1.6 million, compared to $5.0 million in Q3 FY22, with non-GAAP net income of $32.4 million, an increase of 12% compared to $28.9 million in Q3 FY22. • Net loss per diluted share of $0.02, compared to $0.06 in Q3 FY22, with non-GAAP net income per diluted share of $0.38, compared to $0.35 in Q3 FY22.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833622000031/0001428336-22-000031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.